1041878

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 12, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)